Jvion, an Atlanta, GA-based healthcare AI platform provider, received an undisclosed growth equity investment.
Backers included JMI Equity, Health Enterprise Partners and Health Velocity Capital. In conjunction with funding, Matt Emery, General Partner at JMI Equity, joined Jvion’s Board of Directors, along with Sureel Sheth, Principal at JMI.
The company intends to use the funds to:
– further establish its position in healthcare AI – accelerating expansion across the provider market, driving application of its AI platform to other segments including the payor and pharmaceutical markets.
Founded in 2011 by Shantanu Nigam, CEO, Jvion has developed the Cognitive Clinical Success Machine — which uses artificial intelligence to turn healthcare data into prescriptive clinical intelligence, reducing patient-level clinical variation and improving intervention effectiveness. The platform identifies specific patients on a risk trajectory, determines if that trajectory can be changed, and, if so, provides individualized patient-specific interventions that help improve outcomes.